The Effect of Exercise Intervention on the Community's Older Adults
2018年5月11日 更新者:Robert Wen-Wei Hsu、Chang Gung Memorial Hospital
The Effect of Exercise Intervention on the Physical Fitness, Bone Mineral Density and Health-related Quality of Life in the Community's Older Adults
Osteoporosis is a serious global health problem, second only to cardiovascular disease.
Osteoporosis is the most common metabolic bone disease in the elderly population, characterized by loss of bone mineral density (BMD) and continuous destruction of bone microstructure, especially in postmenopausal women.
It gives rise to bone fragility and fracture risk.
Moreover, as people grow older, falls frequently occur with high severity, and nearly 35% to 45% of persons aged 65 or older fall at least once a year.
Osteoporotic fractures increase mortality, morbidity, chronic pain, and the cost of social care and it decreases the quality of life.
Here, investigators plan to perform different exercise interventions such as circuit exercise, aerobic dance and Tai Chi on the community's older adults to evaluate whether exercise intervention could improve the bone mineral density, physical fitness, muscle strength or quality of life.
調査の概要
研究の種類
介入
入学 (実際)
411
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
-
Pizi、台湾、613
- Sports Medicine Center, Chang Gung Memorial Hospital
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
45年~85年 (大人、高齢者)
健康ボランティアの受け入れ
いいえ
受講資格のある性別
全て
説明
Inclusion Criteria:
- Being >45 years-of-age,
- Healthy and physically independent.
Exclusion Criteria:
- The exclusion criteria were individuals on hormone replacement therapy and those with cognitive impairment, progressive debilitating conditions, bone fractures, or any medical contraindications to administering the fitness assessment.
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Control
without exercise intervention
|
|
|
実験的:Exercise
Subjects with circuit exercise, aerobic dance, or Tai Chi exercise intervention.
|
circuit exercise, aerobic dance and Tai Chi exercise
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from baseline bone mineral density
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Bone mineral density measurement is measured by dual-energy x-ray absorptiometry (DXA).
Measurements are made over the lumbar spine and over the upper part of the hip and the measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from baseline elbow muscle strength
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of elbow were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline shoulder muscle strength
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of shoulder were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline hip muscle strength
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of hip were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline knee muscle strength
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Extension and flexion of knee were tested by the HUMAC NORM system (CSMi, Stoughton, MA) with the eccentric/concentric contraction mode at an angular velocity of 60 degrees/s.Isokinetic tests were performed five times for each participant, and each test was separated by a rest period of 3 min.The Muscle strength was present as a peak torque which was normalized to body weight (Unit:Nm/kg).
The participants are assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Change from baseline SF-36 questionnaire assessment
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower score the more disability.
The higher the score the less disability.
Eight sections including physical function, role limitation due to physical problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health.
Additionally, the eight health domains can be used to provide a physical component summary and mental component summary score.
The outcome measurement is assessed at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
High-density lipoprotein from blood sample
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
High-density lipoprotein are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Triglyceride from blood sample
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Triglyceride are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Fasting blood glucose from blood sample
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Fasting blood glucose are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Blood pressure
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Diastolic and systolic blood pressure are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Weight parameters of the subjects
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Weight (kg) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Height parameters of the subjects
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Height (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
|
Waistline parameters of the subjects
時間枠:Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
Waistline (cm) are measured at Pre-intervention, 3-month, 6-month, 9-month-follow-up.
|
Pre-intervention, 3-month, 6-month, 9-month-follow-up
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
捜査官
- 主任研究者:Robert Wen-Wei HSU, MD、Sports Medicine Center, Chang Gung Memorial Hospital, Chiayi
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始
2009年11月1日
一次修了 (実際)
2013年12月1日
研究の完了 (実際)
2013年12月1日
試験登録日
最初に提出
2016年10月13日
QC基準を満たした最初の提出物
2016年10月14日
最初の投稿 (見積もり)
2016年10月18日
学習記録の更新
投稿された最後の更新 (実際)
2018年5月14日
QC基準を満たした最後の更新が送信されました
2018年5月11日
最終確認日
2018年5月1日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- CMRPG690111-3;CMRPG6A0421-22
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
未定
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
代謝性疾患の臨床試験
-
HuidaGene Therapeutics Co., Ltd.募集
-
Hemab ApSPSI CRO募集フォン・ヴィレブランド病(VWD) | フォン・ヴィレブランド病 (VWD)、タイプ 1 | フォンウィルブランド病(VWD)、タイプ2 | Von Willebrand Disease(VWD)、タイプ3 | フォン・ウィルブランド病、タイプ2a | Von Willebrand病、タイプ2M | Von Willebrand病、タイプ2Nアメリカ, イギリス, オーストラリア
-
Adelphi Values LLCBlueprint Medicines Corporation完了肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されましたアメリカ
exerciseの臨床試験
-
National Taiwan Normal University完了
-
University of Erlangen-Nürnberg Medical SchoolKlinikum Nürnberg完了
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for Clinical... と他の協力者完了
-
Chonticha KaewjohoUniversity of Phayao完了
-
Shanghai Jiao Tong University School of Medicine完了